Dengue Death Review: A Tool to Adjudge the Cause of Dengue Mortality and Use of the Tool for Prevention of Dengue Deaths

Dengue is a mosquito-borne viral disease endemic in many countries in the tropics and sub-tropics. The state of Punjab in India shows cyclical and seasonal variation in dengue cases. The Case Fatality Rate of Dengue has ranged from 0.6 to 1.0 in the past years. The department has initiated review of the cases that have died due to dengue in order to know the exact cause of the death in a case of dengue. The study has been undertaken to know the other associated co-morbidities and factors causing death in a case of dengue. The study used the predesigned proforma on which the records (medical and Lab) were recorded and reviewed by the expert committee of the doctors. This study has revealed that cases of dengue having co-morbidities have longer stay in hospital. Fluid overload and co-morbidities have been found as major factors leading to death, however, in a confirmed case of dengue hepatorenal shutdown was found to be major cause of mortality. The data obtained will help in sensitizing the treating physicians in order to decrease the mortality due to dengue in future.

Authors:

• Gagandeep Singh Grover
• Vini Mahajan
• Bhagmal
• Priti Thaware
• Jaspreet Takkar

Keywords:

• Dengue
• death
• morbidities
• DHF
• DSS.

References:

[1] World Health Organization (WHO) and the Special Programme for
Research and Training in Tropical Diseases (TDR): Dengue: guidelines
for diagnosis, treatment, prevention and control Geneva: WHO; 2009,
New Edition.
[2] Ooi EE, Goh KT, Gubler DJ: Dengue prevention and 35 years of vector
control in Singapore. Emerg Infect Dis 2006, 12(6):887-893.
[3] World Health Organization (WHO): Dengue Haemorrhagic Fever:
Diagnosis,Treatment, Prevention and Control. 2 edition. Geneva: WHO;
1997.
[4] Bandyopadhyay S, Lum LC, Kroeger A: Classifying dengue: a review of
thedifficulties in using the WHO case classification for dengue
haemorrhagic fever. Trop Med Int Health 2006, 11(8):1238-1255.
[5] National Guidelines for Clinical Management of Dengue Fever. National
Vector Borne Disease Control Programme, Govt. of India: 2014.
[6] World Health Organization (WHO): Handbook for clinical management
of dengue. 2012.
[7] World Health Organization (WHO): Dengue/ Dengue Haemorrhagic
Fever. Prevention and Control.SEA-Haem.Fev-75, 2002.
[8] World Health Organization (WHO): Guidelines for treatment of Dengue
and Dengue Haemorrhagic Fever in small Hospitals. ROF-SEA, 1999.
[9] World Health Organization (WHO): Comprehensive Guidelines for
Prevention and Control of Dengue and DHF. Revised and Expanded
edition. 2011.
[10] Clinical Practice Guidelines. Management of Dengue Infection in
Adults. MOH/PAK/209.10 (GU).
[11] Guidelines for Clinical Management of Dengue Fever, Dengue
Haemorrhagic Fever and Dengue Shock Syndrome. Department of
National Vector Borne Disease Control Programme, Directorate of
Health Services, Govt. of India. 2008.
[12] World Health Organization (WHO): Prevention and Control of Dengue
and DHF. Comprehensive Guidelines. WHO Regional Publication,
SEARO No. 29. 1995.
[13] CDC: Dengue and Dengue Haemorrhagic Fever. Information for
Healthcare Practitioners. US Department of Health and Human Services.
Centre for Disease Cntrol and Prevention.